summary
Introduced
01/13/2026
01/13/2026
In Committee
02/03/2026
02/03/2026
Crossed Over
Passed
Dead
Introduced Session
104th General Assembly
Bill Summary
Creates the Illinois Psilocybin Advisory Board Act. Sets forth findings and defines terms. Establishes the Illinois Psilocybin Advisory Board within the Department of Financial and Professional Regulation for the purpose of advising and making recommendations to the Department regarding the provision of psilocybin and psilocybin services. Sets forth requirements for members of the Board. Provides that, within 3 months after the effective date of the Act, the Governor, the Senate President, the Speaker of the House, the Minority Leader of the House, and the Minority Leader of the Senate shall appoint certain individuals to the Board. Provides that, between January 1, 2027 and January 1, 2029, the Board shall meet at least once every 2 calendar months at a time and place determined by the chairperson or a majority of the voting members of the Board and that, after January 1, 2029, the Board shall meet at least once every calendar quarter. Provides that the Board shall perform certain duties, including publishing an annual report describing the Board's activities and making recommendations concerning (i) the safety and efficacy of psilocybin and other substances, (ii) potential requirements for providing psilocybin services to clients, (iii) a potential code of ethics and possible training requirements for facilitators, and (iv) public health considerations. Makes other changes. Effective immediately.
AI Summary
This bill establishes the Illinois Psilocybin Advisory Board Act, creating an advisory board within the Department of Financial and Professional Regulation to guide the state on the provision of psilocybin, a substance found in psychedelic mushrooms, and related services. The board, composed of various state officials, medical professionals, researchers, and advocates, will be responsible for making recommendations on the safety and efficacy of psilocybin and other entheogens (psychoactive substances like MDMA and LSD), potential requirements for psilocybin services including preparation, administration, and integration sessions, and a code of ethics and training for facilitators who guide individuals through these experiences. The board will also consider public health implications and study other states' approaches to regulating these substances, with a mandate to publish an annual report detailing its activities and recommendations, and will meet regularly to fulfill its duties.
Committee Categories
Government Affairs
Sponsors (4)
Last Action
Added as Co-Sponsor Sen. Mike Simmons (on 02/19/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...